personalised medicine Archives -

Cancer/ Oncology/ Views & Analysis/ Views and analysis

At ESMO 2022, oncologists saw exciting cancer advances

mike.hammerton@pharmaphorum.com cancer, cancer treatment, ESMO, immunotherapy, Life Sciences, market insight, Oncology, personalised medicine 0 Comment

Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to the march towards

At ESMO 2022, oncologists saw exciting cancer advances

https://pharmaphorum.com/views-and-analysis/at-esmo-2022-oncologists-saw-exciting-cancer-advances/

News/ News/ News/ Oncology/ R&D

Merck gets on board with Moderna cancer vaccine in $250m deal

Phil Taylor cancer vaccine, immuno-oncology, melanoma, Merck & Co, Moderna, Oncology, partnering, personalised medicine 0 Comment

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised

Merck gets on board with Moderna cancer vaccine in $250m deal

https://pharmaphorum.com/news/merck-gets-on-board-with-moderna-cancer-vaccine-in-250m-deal/

Digital/ Views & Analysis/ Views and analysis

The NIH on accelerating research using diverse biomedical datasets

Jessica Hagen All of Us, biomedical research, biosamples, data, diversity, mobile engagement asset, NIH, personalised medicine 0 Comment

Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program

The NIH on accelerating research using diverse biomedical datasets

https://pharmaphorum.com/views-and-analysis/the-nih-on-accelerating-research-using-diverse-biomedical-datasets/

Digital/ News/ News/ News/ Oncology

EU-based I3LUNG project applying AI to lung cancer care gets underway

Phil Taylor artificial intelligence, digital, digital health, I3LUNG, Oncology, personalised medicine 0 Comment

An EU-funded project that aims to encourage the implementation of artificial intelligence-based personalised care for lung cancer patients

EU-based I3LUNG project applying AI to lung cancer care gets underway

https://pharmaphorum.com/news/eu-based-i3lung-project-applying-ai-to-lung-cancer-care-gets-underway/

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

Digital/ News/ News

AI test could predict best cancer therapies for patients

Phil Taylor artificial intelligence, digital, digital health, Non-small cell lung cancer, Oncology, personalised medicine 0 Comment

Researchers at the Institute of Cancer Research (ICR) in London have designed a prototype test that they think

AI test could predict best cancer therapies for patients

https://pharmaphorum.com/news/ai-test-could-predict-best-cancer-therapies-for-patients/

The state of personalised medicine In 2019

R&D/ Views & Analysis/ Views and analysis

Herd immunity is nice – but what about me?

Catherine Longworth antibody testing, COVID-19, immunity, personalised medicine 0 Comment

Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing. To-date, the battle against COVID-19

Herd immunity is nice – but what about me?

https://pharmaphorum.com/views-and-analysis/herd-immunity-is-nice-but-what-about-me/

Digital/ Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

A roadmap for adopting New Science

George Underwood Accenture, Innovation, personalised medicine, reimbursement 0 Comment

The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community

A roadmap for adopting New Science

https://pharmaphorum.com/market-access-2/a-roadmap-for-adopting-new-science/

Digital/ News/ News

COSMIC database matches drugs to cancer mutations

Phil Taylor cancer, digital, Oncology, personalised medicine, precision medicine, Sanger Institute, Wellcome 0 Comment

The world’s largest database of cancer mutations can now be used to link mutations with drug treatments in

COSMIC database matches drugs to cancer mutations

https://pharmaphorum.com/news/cosmic-database-matches-drugs-to-cancer-mutations/

R&D/ Views & Analysis/ Views and analysis

Could personalised medicine change treatment for migraine?

Richard Staines Curelator, migraine, migraine treatment, N1-Headache, personalised medicine 0 Comment

The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific

Could personalised medicine change treatment for migraine?

https://pharmaphorum.com/views-and-analysis/could-personalised-medicine-change-treatment-for-migraine/

Trending

personalised medicine

Login